BioCentury
ARTICLE | Clinical News

ItMSCs: Phase III started

February 24, 2014 8:00 AM UTC

Stemedica's CardioCell LLC subsidiary said Kazakhstan's National Scientific Medical Center began a Kazakhstani Phase III trial to evaluate IV itMSCs in about 120 patients with acute MI. Altaco XXI (As...